Komplikasyondan tanıya: Vena kava superior sendromundan Behçet hastalığına

Yıl 2015, Cilt: 25 Sayı: 1, 23 - 25, 01.03.2015

Turgay Albayrak Emrah Günay Selim Ünsal İrfan Şencan İsmail Kasım Rabia Kahveci Adem Özkara

Öz

Vena kava superior sendromunun VKSS belirti ve bulgularını damar tıkanıklığının seviyesi, şiddeti, süresi ile kollateral gelişimi belirlemektedir. Ayrıca hastalığın altında yatan nedene göre de belirti ve bulgulara rastlanabilir. Behçet Hastalığı damar tutulumuna bağlı olarak VKSS’una neden olabilmektedir. Türkiye, Behçet Hastalığının görülme sıklığı yüksek olan ülkelerden biridir. Bu olguda boyunda şişlik, nefes darlığı ve baş dönmesi ile başvuran hastada, Behçet Hastalığının neden olduğu VKSS anlatılmıştır

Anahtar Kelimeler

Vena kava superior sendromu, Behçet Hastalığı, damar tutulumu

Complications to reach the diagnosis: The superior vena cava syndrome to reach Behçet’s disease

Öz

The superior vena cava syndrome’s SVCS signs and symptoms are determined by vascular congestion level, intensity, duration and the development of the collaterals. SVCS’s signs and symptoms are occured according to the underlying cause of the disease. Behçet’s disease can cause to SVCS by vascular involvement. Turkey is one of the countries with a high prevalence of Behçet’s disease. In this case, we diagnosed Behçet’s disease in a patient with swelling of the neck, shortness of breath and dizziness

Anahtar Kelimeler

The superior vena cava syndrome, Behçet’s disease, vascular involvement

Kaynakça

• Ozbek IC, Sever K, Mansuroğlu D, Kaçar S. Surgical treatment of catheter related superior vena cava syndrome without cardiopul- monary bypass in a patient with renal transplantation. Turk Gogus Kalp Damar 2013;21:187-90.
• Kansu E, Ozer FL, Akalin E, et al. Behcet’s syndrome with obst- ruction of the venae cavae. A report of seven cases. Q J Med 1972;41:151-68.
• Espitia O, Guerin P, Neel A, et al. Superior vena cava syndrome induced by pacemaker probes, 12 years after introduction. J Mal Vasc 2013;38:193-7.
• Rachapalli V, Boucher LM. Superior vena cava syndrome: role of the interventionalist. Can Assoc Radiol J 2014;65:168-76.
• Marshall SE. Behcet’s disease. Best Pract Res Clin Rheumatol 2004;18:291-311.
• Pandrea A, Rudinskaya A, Klein B, Krebs T. What does it take to diagnose Behcet disease? J Clin Rheumatol 2007;13:31-4.
• Alpsoy E, Yilmaz E, Coskun M, Savas A, Yegin O. HLA antigens and linkage disequilibrium patterns in Turkish Behcet’s patients. J Dermatol 1998;25:158-62.
• Yurdakul S, Yazici H. Behcet’s syndrome. Best Pract Res Clin Rheu- matol 2008;22:793-809.
• Tan RA, Karabulut HG, Boyvat A, Bökesoy I. Glu298Asp, -786T>C, and ıntron 4 a/b polymorphisms of endothelial nitric oxide syntha- se gene in behçet’s disease. Turk J Rheumatol 2011;26:210-6.
• Yurdakul S, Erdemir VA, Yildirimturk O, Gurel MS, Aytekin S. Evaluation of endothelial functions in patients with Behcet’s dise- ase without overt vascular involvement. Turk Kardiyol Dern Ars 2012;40:518-22.
• Wan JF, Bezjak A. Superior vena cava syndrome. Hematol Oncol Clin North Am 2010;24:501-13.